Benjamin F. Edwards & Company’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-477
Closed -$15K 2248
2023
Q4
$15K Buy
477
+250
+110% +$8.98K ﹤0.01% 1560
2023
Q3
$9K Sell
227
-250
-52% -$11.7K ﹤0.01% 1430
2023
Q2
$25K Hold
477
﹤0.01% 1229
2023
Q1
$31K Hold
477
﹤0.01% 1193
2022
Q4
$23K Hold
477
﹤0.01% 1249
2022
Q3
$34K Hold
477
﹤0.01% 1147
2022
Q2
$34K Sell
477
-250
-34% -$16.1K ﹤0.01% 1129
2022
Q1
$58K Hold
727
﹤0.01% 984
2021
Q4
$66K Hold
727
﹤0.01% 974
2021
Q3
$93K Buy
727
+1
+0.1% +$140 ﹤0.01% 869
2021
Q2
$111K Hold
726
0.01% 820
2021
Q1
$77K Hold
726
﹤0.01% 903
2020
Q4
$58K Sell
726
-1,000
-58% -$73.2K ﹤0.01% 936
2020
Q3
$98K Buy
1,726
+1,476
+590% +$79.5K 0.01% 746
2020
Q2
$15K Buy
+250
New +$10.2K ﹤0.01% 1195

Other funds holding STAA

Benjamin F. Edwards & Company's STAA Position: Q1 2024 in Review

Benjamin F. Edwards & Company sold out of STAAR Surgical (STAA) in Q1 2024, closing a stake of 477 shares — an estimated $15K sold.

Benjamin F. Edwards & Company first reported a position in STAA in Q2 2020 and held it in 15 quarters. The position peaked at $111K in Q2 2021. 197 funds tracked by Wall St. Rank hold STAA as of Q1 2024.

  • Benjamin F. Edwards & Company reported no remaining STAAR Surgical position as of Q1 2024 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 477 STAAR Surgical shares in Q1 2024, an estimated $15K.
  • Benjamin F. Edwards & Company first reported a position in STAAR Surgical in Q2 2020 and held it in 15 quarters.
  • Benjamin F. Edwards & Company's STAAR Surgical position peaked at $111K in Q2 2021.
  • 197 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q1 2024, filed 29 Apr 2024.